drugset / Trial / NCT06974565
A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the pharmacokinetics (PK) and safety of AZD2389 when administered alone and in combination with quinidine in healthy participants.
Timeline
- Start
- 2025-05-12
- Primary completion
- 2025-07-18
- Completion
- 2025-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD2389 | Small molecule | — | Oral |
| Subject | Quinidine | Small molecule | — | Oral |